{
  "Q0": "Neuromuscular gene panel testing",
  "Q1": "Yes",
  "Q2": "No",
  "Q3": "No",
  "Q4": "Yes",
  "Q4.1": "No",
  "Q4.1.1": "None of the above",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "No",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81448",
  "Q15": "No",
  "Q16": "No",
  "Q17": "According to the policy, the patient would need to first undergo appropriate clinical evaluation including a neurologic exam and serum CK testing to establish that an inherited peripheral neuropathy is suspected based on signs/symptoms. The policy requires that a definitive diagnosis cannot be made without genetic testing. Additionally, genetic counseling is recommended in the policy guidelines. The test should be ordered by a provider with expertise in genetic medicine and genetic testing methods.",
  "match": false
}